OBJECTIVE. Atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), and
lobular carcinoma in situ (LCIS) are among high-risk lesions that have been previously …

Lobular neoplasia and atypical ductal hyperplasia (ADH) are high-risk breast lesions
associated with an increased risk of breast cancer. Until recently, surgical excision was …

OBJECTIVE. The purpose of this article is to determine the upgrade rate to ductal carcinoma
in situ (DCIS) or invasive carcinoma at excision at the same site after percutaneous breast …

BACKGROUND Approximately 25% of all cases of atypical ductal hyperplasia (ADH)
diagnosed on core biopsy of the breast are associated with ductal carcinoma in situ (DCIS) …

Abstract Purpose of Review The aim of this review is to summarize recently published
literature addressing atypical ductal hyperplasia (ADH), lobular neoplasia (atypical lobular …

PURPOSE: To retrospectively determine frequency of invasive cancer or ductal carcinoma in
situ (DCIS) at excisional biopsy in women with atypical lobular hyperplasia (ALH) or lobular …

Atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) diagnosed in core
needle biopsy (CNB) are generally regarded as risk indicators for developing invasive …

Atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), and lobular
carcinoma in situ (LCIS) are commonly seen on breast core needle biopsy (CNB). Many …

Atypical ductal hyperplasia (ADH) and lobular carcinoma in situ (LCIS) may be associated
with a relatively high incidence of invasive carcinoma and ductal carcinoma in situ (DCIS) on …

OBJECTIVE. The aims of our study were to determine the frequency of malignancy after
surgical excision of biopsy-proven lobular carcinoma in situ (LCIS) or atypical lobular …